S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
S&P 500   3,829.34
DOW   31,402.01
QQQ   312.83
Log in
NASDAQ:EXPO

Exponent Stock Forecast, Price & News

$97.63
-1.52 (-1.53 %)
(As of 02/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$97.18
Now: $97.63
$100.94
50-Day Range
$82.58
MA: $92.25
$99.15
52-Week Range
$58.03
Now: $97.63
$100.94
Volume301,328 shs
Average Volume229,190 shs
Market Capitalization$5.04 billion
P/E Ratio65.09
Dividend Yield0.77%
Beta0.32
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, thermal sciences, and vehicle analysis. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 different technical disciplines to solve complicated issues facing industry and government. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.
Exponent logo

Industry, Sector and Symbol

Industry Management consulting services
Sub-IndustryResearch & Consulting Services
Current SymbolNASDAQ:EXPO
CUSIP30214U10
Phone650-326-9400
Employees901
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$417.20 million
Cash Flow$1.78 per share
Book Value$6.76 per share

Profitability

Net Income$82.46 million

Miscellaneous

Market Cap$5.04 billion
Next Earnings Date4/29/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.65 out of 5 stars

Business Services Sector

77th out of 440 stocks

Management Consulting Services Industry

8th out of 46 stocks

Analyst Opinion: 1.3Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
$97.63
-1.52 (-1.53 %)
(As of 02/25/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EXPO News and Ratings via Email

Sign-up to receive the latest news and ratings for EXPO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Exponent (NASDAQ:EXPO) Frequently Asked Questions

Is Exponent a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Exponent stock.
View analyst ratings for Exponent
or view top-rated stocks.

What stocks does MarketBeat like better than Exponent?

Wall Street analysts have given Exponent a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Exponent wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Exponent's next earnings date?

Exponent is scheduled to release its next quarterly earnings announcement on Thursday, April 29th 2021.
View our earnings forecast for Exponent
.

How were Exponent's earnings last quarter?

Exponent, Inc. (NASDAQ:EXPO) issued its quarterly earnings data on Thursday, February, 4th. The business services provider reported $0.41 EPS for the quarter, beating the consensus estimate of $0.28 by $0.13. Exponent had a net margin of 19.63% and a trailing twelve-month return on equity of 23.66%.
View Exponent's earnings history
.

How has Exponent's stock been impacted by COVID-19?

Exponent's stock was trading at $75.99 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, EXPO stock has increased by 28.5% and is now trading at $97.63.
View which stocks have been most impacted by COVID-19
.

How often does Exponent pay dividends? What is the dividend yield for Exponent?

Exponent declared a quarterly dividend on Thursday, February 4th. Stockholders of record on Friday, March 12th will be given a dividend of $0.20 per share on Friday, March 26th. This represents a $0.80 annualized dividend and a yield of 0.82%. The ex-dividend date is Thursday, March 11th. This is a boost from Exponent's previous quarterly dividend of $0.19.
View Exponent's dividend history
.

Is Exponent a good dividend stock?

Exponent pays an annual dividend of $0.76 per share and currently has a dividend yield of 0.77%. Exponent does not yet have a strock track record of dividend growth. The dividend payout ratio of Exponent is 49.67%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Exponent will have a dividend payout ratio of 46.91% next year. This indicates that Exponent will be able to sustain or increase its dividend.
View Exponent's dividend history.

When did Exponent's stock split? How did Exponent's stock split work?

Exponent's stock split before market open on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly created shares were payable to shareholders after the closing bell on Wednesday, June 6th 2018. An investor that had 100 shares of Exponent stock prior to the split would have 200 shares after the split.

What price target have analysts set for EXPO?

2 analysts have issued 12 month target prices for Exponent's shares. Their forecasts range from $94.00 to $94.00. On average, they expect Exponent's share price to reach $94.00 in the next year. This suggests that the stock has a possible downside of 3.7%.
View analysts' price targets for Exponent
or view top-rated stocks among Wall Street analysts.

Who are Exponent's key executives?

Exponent's management team includes the following people:
  • Dr. Catherine Ford Corrigan, Pres, CEO & Director (Age 52, Pay $1.35M)
  • Mr. Richard L. Schlenker Jr., Exec. VP, CFO & Corp. Sec. (Age 55, Pay $989.94k)
  • Ms. Sally B. Shepard, Chief HR Officer (Age 60, Pay $658.6k)
  • Dr. Harri K. Kytomaa, Group VP and Principal Engineer Mechanical & Thermal (Age 62, Pay $715.82k)
  • Dr. Steven J. Murray, Group VP & Principal Engineer (Age 46, Pay $781.32k)
  • Dr. Bernard Ross, Co-Founder, Chairman Emeritus & Principal Engineer
  • Dr. Subbaiah V. Malladi, CTO & Principal Engineer (Age 74)
  • Mr. Eric R. Anderson, VP & Corp. Controller
  • Dr. Robert D. Caligiuri, Corp. VP of Materials & Corrosion Engineering and Principal Engineer (Age 69)
  • Dr. Paul D. Boehm, Corp. VP of Environmental & Health Sciences and Principal Scientist (Age 72)

What is Catherine Corrigan's approval rating as Exponent's CEO?

15 employees have rated Exponent CEO Catherine Corrigan on Glassdoor.com. Catherine Corrigan has an approval rating of 84% among Exponent's employees.

Who are some of Exponent's key competitors?

What other stocks do shareholders of Exponent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Pfizer (PFE), Abbott Laboratories (ABT), Energy Transfer (ET), Ford Motor (F), Micron Technology (MU), AT&T (T), UnitedHealth Group (UNH), Visa (V) and Adobe (ADBE).

What is Exponent's stock symbol?

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

Who are Exponent's major shareholders?

Exponent's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.51%), Conestoga Capital Advisors LLC (3.81%), Dimensional Fund Advisors LP (2.12%), Price T Rowe Associates Inc. MD (2.08%), Riverbridge Partners LLC (1.95%) and Northern Trust Corp (1.60%). Company insiders that own Exponent stock include Bradley A James, Carol Lindstrom, Harri Kytomaa, John Pye, Maureen T F Reitman, Paul R Johnston, Richard L Schlenker Jr, Richard Reiss, Sally Shepard and Steven J Murray.
View institutional ownership trends for Exponent
.

Which institutional investors are selling Exponent stock?

EXPO stock was sold by a variety of institutional investors in the last quarter, including The Manufacturers Life Insurance Company , Morgan Stanley, Nuveen Asset Management LLC, Copeland Capital Management LLC, Panagora Asset Management Inc., Redwood Investments LLC, Epoch Investment Partners Inc., and Los Angeles Capital Management LLC. Company insiders that have sold Exponent company stock in the last year include Bradley A James, Carol Lindstrom, Harri Kytomaa, Maureen T F Reitman, Paul R Johnston, Richard L Schlenker Jr, Richard Reiss, Sally Shepard, and Steven J Murray.
View insider buying and selling activity for Exponent
or view top insider-selling stocks.

Which institutional investors are buying Exponent stock?

EXPO stock was bought by a variety of institutional investors in the last quarter, including Ardevora Asset Management LLP, BlackRock Inc., Roffman Miller Associates Inc. PA, Westpac Banking Corp, Rheos Capital Works Inc., Canada Pension Plan Investment Board, Guardian Capital LP, and Riverbridge Partners LLC.
View insider buying and selling activity for Exponent
or or view top insider-buying stocks.

How do I buy shares of Exponent?

Shares of EXPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Exponent's stock price today?

One share of EXPO stock can currently be purchased for approximately $97.63.

How much money does Exponent make?

Exponent has a market capitalization of $5.04 billion and generates $417.20 million in revenue each year. The business services provider earns $82.46 million in net income (profit) each year or $1.53 on an earnings per share basis.

How many employees does Exponent have?

Exponent employs 901 workers across the globe.

What is Exponent's official website?

The official website for Exponent is www.exponent.com.

Where are Exponent's headquarters?

Exponent is headquartered at 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025.

How can I contact Exponent?

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The business services provider can be reached via phone at 650-326-9400 or via email at [email protected]


This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.